Thomas Tray is the Vice President, Chief Accounting Officer, and Principal Financial Officer at Incyte Corporation, a global biopharmaceutical company focused on oncology and inflammation. In this critical role, he leads the accounting organization, overseeing financial reporting, SEC filings, internal controls, technical accounting, and compliance with U.S. GAAP and SOX requirements. Tray ensures the accuracy, timeliness, and transparency of Incyte's financial statements, supporting the company's strategic initiatives and investor relations amid rapid growth and product launches. With more than 25 years of experience in finance and accounting within the pharmaceutical and biotechnology sectors, Tray joined Incyte in 2017 as Vice President and Corporate Controller before advancing to his current position. Previously, he served as Vice President and Corporate Controller at Endo Pharmaceuticals, where he managed global financial reporting, Sarbanes-Oxley compliance, and integration efforts following major acquisitions. Earlier, Tray held senior audit roles at Deloitte & Touche, providing expertise to life sciences clients on complex revenue recognition, business combinations, and regulatory matters. Tray's achievements include strengthening Incyte's financial controls during periods of expansion, facilitating successful equity offerings and partnerships, and enhancing operational efficiencies that have bolstered the company's market position. His strategic foresight and deep industry knowledge have been pivotal in maintaining Incyte's strong financial foundation, enabling sustained investment in innovative therapies for patients worldwide.